Table 3.
AFIF's action on the mean contractile frequency of PCSMS (mean ± SD).
| Administration | N | Mean contractile frequency (beat per minute, BPM) | ||
|---|---|---|---|---|
| Ca2+-lack | Ca2+-normal | Ca2+-rich | ||
| NS (control) | 10 | 3.58 ± 0.79 | 3.57 ± 0.56 | 4.30 ± 0.83 |
| AFIF, 3 μg/mL | 10 | 3.63 ± 0.74 | 3.52 ± 0.53 | 4.37 ± 0.96 |
| AFIF, 30 μg/mL | 10 | 3.68 ± 0.90 | 3.49 ± 0.54 | 4.28 ± 0.81 |
| AFIF, 300 μg/mL | 10 | 3.57 ± 0.60 | 3.39 ± 0.74 | 4.37 ± 0.91 |
| AFIF, 3000 μg/mL | 10 | 3.62 ± 1.47 | 3.49 ± 1.09 | 4.69 ± 0.89 |
| AFIF, 6000 μg/mL | 10 | 2.16 ± 2.10 | 3.0 ± 0.96 | 4.16 ± 0.74 |
| AFIF, 10000 μg/mL | 10 | 0.62 ± 1.40b | 1.63 ± 1.30b | 2.75 ± 1.60b |
b P < 0.01 versus control.